BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29174979)

  • 1. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
    Xu G; Cai J; Wang L; Jiang L; Huang J; Hu R; Ding F
    Exp Cell Res; 2018 Jan; 362(2):268-278. PubMed ID: 29174979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-30e-5p inhibits proliferation and metastasis of nasopharyngeal carcinoma cells by target-ing USP22.
    Ma YX; Zhang H; Li XH; Liu YH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6342-6349. PubMed ID: 30338802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circRNA circFAT1(e2) Elevates the Development of Non-Small-Cell Lung Cancer by Regulating miR-30e-5p and USP22.
    Dong W; Zhang H; Dai Y; Zhou Y; Luo Y; Zhao C; Cao Y; Du Y; Chen Y
    Biomed Res Int; 2021; 2021():6653387. PubMed ID: 33884267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
    Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
    Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
    Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
    Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9.
    Cui Y; Zhao L; Zhao S; Guo T; Li F; Li Z; Fang L; Wu T; Gu C
    Hum Cell; 2019 Jul; 32(3):326-333. PubMed ID: 31079325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
    Dao R; Wudu M; Hui L; Jiang J; Xu Y; Ren H; Qiu X
    Pathol Res Pract; 2020 Mar; 216(3):152823. PubMed ID: 31983569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 13. Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1.
    Ao N; Liu Y; Feng H; Bian X; Li Z; Gu B; Zhao X; Liu Y
    Cell Physiol Biochem; 2014; 33(6):1863-75. PubMed ID: 24969755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p.
    Li J; Song Y; Yu B; Yu Y
    DNA Cell Biol; 2020 Jul; 39(7):1256-1263. PubMed ID: 32456459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling.
    Huang X; Xiao S; Zhu X; Yu Y; Cao M; Zhang X; Li S; Zhu W; Wu F; Zheng X; Jin L; Xie C; Huang X; Zou P; Li X; Cui R
    Cell Death Dis; 2020 Sep; 11(9):785. PubMed ID: 32963220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
    Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
    J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
    Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
    J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.
    Li G; Wang K; Wang J; Qin S; Sun X; Ren H
    J Cell Biochem; 2019 Jun; 120(6):10587-10595. PubMed ID: 30816573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
    Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.